Filing Flows › Oscar Health (OSCR) › Q3 2025
Oscar Health (OSCR) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 6, 2025
Oscar Health (OSCR) reported revenue of $3.0B for the third quarter 2025 (Q3 2025), +23% from a year earlier and +4% from the quarter before. Operating margin was -4.3%, net loss $137M (4.6% of revenue).
Oscar Health, Q3 2025: revenue $3.0B (+23% year over year), operating margin -4.3%, net loss $137M, operating cash flow −$965M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.0B | +4% | +23% |
| Operating profit | −$129M | — | — |
| Net earnings | −$137M | — | — |
| Operating cash flow | −$965M | -289% | — |
What changed
Revenue was $3.0B in Q3 2025, up 23% year over year and up 4% from the previous quarter.
Operating costs exceeded revenue by $0.13B, an operating margin of -4.3%. Total costs grew 26% against revenue growth of 23%. The fastest-growing cost line was Other operating costs (+29%). The quarter ended with a net loss of $0.14B, narrower than the previous quarter's $0.23B loss.
Operating cash flow was −$1.0B. Non-cash charges added back $0.01B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.85B. Capital expenditures of $0.01B exceeded it, leaving free cash flow of −$1.0B.
Questions
What was Oscar Health's revenue in the third quarter 2025?
Oscar Health (OSCR) reported revenue of $3.0B for the third quarter 2025 (Q3 2025), +23% from a year earlier and +4% from the quarter before.
Was Oscar Health profitable in the third quarter 2025?
Operating loss was $129M (-4.3% of revenue) and net loss $137M.
Source: Oscar Health 10-Q on SEC EDGAR.